Eagle Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-362,092
Closed -$11.8M 542
2022
Q3
$11.8M Buy
362,092
+1,915
+0.5% +$79K 0.08% 215
2022
Q2
$14.2M Buy
360,177
+8,704
+2% +$465K 0.09% 207
2022
Q1
$24.6M Buy
351,473
+5,050
+1% +$369K 0.13% 179
2021
Q4
$27M Sell
346,423
-44,768
-11% -$3.95M 0.12% 190
2021
Q3
$37.3M Sell
391,191
-2,576
-0.7% -$272K 0.17% 173
2021
Q2
$48.9M Sell
393,767
-182
-0% -$21.7K 0.21% 158
2021
Q1
$52.2M Buy
+393,949
New +$53.9M 0.23% 157
2020
Q3
Sell
-39,183
Closed -$3.37M 581
2020
Q2
$3.37M Sell
39,183
-951,327
-96% -$76M 0.02% 405
2020
Q1
$57.4M Sell
990,510
-68,247
-6% -$5.54M 0.36% 104
2019
Q4
$97.9M Sell
1,058,757
-33,251
-3% -$2.92M 0.47% 70
2019
Q3
$98.7M Sell
1,092,008
-9,727
-0.9% -$1.11M 0.51% 57
2019
Q2
$130M Buy
1,101,735
+5,112
+0.5% +$515K 0.67% 25
2019
Q1
$95M Buy
1,096,623
+100,072
+10% +$8.52M 0.51% 52
2018
Q4
$62.9M Sell
996,551
-231,132
-19% -$15.9M 0.4% 87
2018
Q3
$96.9M Buy
1,227,683
+388,434
+46% +$25.3M 0.47% 58
2018
Q2
$50.2M Sell
839,249
-935,301
-53% -$50.3M 0.27% 147
2018
Q1
$71.6M Sell
1,774,550
-18,777
-1% -$916K 0.39% 88
2017
Q4
$93.9M Sell
1,793,327
-39,975
-2% -$2.13M 0.52% 47
2017
Q3
$87.9M Sell
1,833,302
-23,883
-1% -$961K 0.5% 45
2017
Q2
$65.7M Buy
1,857,185
+304,598
+20% +$9.4M 0.4% 72
2017
Q1
$36.7M Sell
1,552,587
-9,795
-0.6% -$194K 0.23% 142
2016
Q4
$20.9M Buy
1,562,382
+832,133
+114% +$13.4M 0.14% 216
2016
Q3
$13.6M Buy
+730,249
New +$12.9M 0.09% 288
2015
Q4
Sell
-1,108,447
Closed -$19.9M 639
2015
Q3
$19.9M Buy
+1,108,447
New +$25.5M 0.14% 211

Other funds holding EXAS

Eagle Asset Management's EXAS Position: Q4 2022 in Review

Eagle Asset Management sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 362,092 shares — an estimated $11.8M sold.

Eagle Asset Management first reported a position in EXAS in Q3 2015 and held it in 24 quarters. The position peaked at $130M in Q2 2019. 552 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • Eagle Asset Management reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
  • Eagle Asset Management sold 362,092 Exact Sciences shares in Q4 2022, an estimated $11.8M.
  • Eagle Asset Management first reported a position in Exact Sciences in Q3 2015 and held it in 24 quarters.
  • Eagle Asset Management's Exact Sciences position peaked at $130M in Q2 2019.
  • 552 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Eagle Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.